Income Taxes (Details) - Hong Kong [Member] |
12 Months Ended | ||
|---|---|---|---|
|
Mar. 31, 2025
USD ($)
|
Mar. 31, 2025
HKD ($)
|
Mar. 31, 2024
HKD ($)
|
|
| Income Taxes [Line Items] | |||
| Percentage of reduction granted | 100.00% | 100.00% | |
| Amount of tax payable subject to a maximum reduction | $ 1,500 | $ 3,000 | |
| Minimum [Member] | |||
| Income Taxes [Line Items] | |||
| Percentage of assessable profits | 8.25% | 8.25% | |
| Assessable profits | $ 256,664 | $ 2,000,000 | |
| Maximum [Member] | |||
| Income Taxes [Line Items] | |||
| Percentage of assessable profits | 16.50% | 16.50% | |
| Assessable profits | $ 256,664 | $ 2,000,000 | |
| X | ||||||||||
- Definition Percentage of domestic federal statutory tax rate applicable to pretax income (loss). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operations attributable to deduction. Includes, but is not limited to, dividend deduction, deduction for dividend paid to employee stock ownership plan (ESOP), Medicare prescription drug benefit subsidy deduction, and other deductions. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Definition Amount of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operations attributable to deduction. Includes, but is not limited to, dividend deduction, deduction for dividend paid to employee stock ownership plan (ESOP), Medicare prescription drug benefit subsidy deduction, and other deductions. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|